23 results
DEF 14C
SHPH
Shuttle Pharmaceuticals Holdings Inc
16 Jun 23
Information statement
6:30am
approving, for purposes of Nasdaq Listing Rule 5635(d) (“Nasdaq Rule 5635(d)”), by written consent in lieu of a special meeting dated May 4, 2023 … of the State of Delaware (the “DGCL”), which provides that any action that may be taken at any annual or special meeting of stockholders may be taken without
PRE 14C
SHPH
Shuttle Pharmaceuticals Holdings Inc
5 Jun 23
Preliminary information
4:29pm
approving, for purposes of Nasdaq Listing Rule 5635(d) (“Nasdaq Rule 5635(d)”), by written consent in lieu of a special meeting dated May 4, 2023 … of the State of Delaware (the “DGCL”), which provides that any action that may be taken at any annual or special meeting of stockholders may be taken without
8-K
EX-3.1
SHPH
Shuttle Pharmaceuticals Holdings Inc
1 Nov 22
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
9:00am
of the Corporation. Notice of a Special Meeting stating the place, date and hour of the meeting, the means of remote communications, if any, by which … in the notice of special meeting shall come before such meeting.
Section 4. Quorum. Except as otherwise provided by law or by the Certificate
DRS
SHPH
Shuttle Pharmaceuticals Holdings Inc
29 Sep 22
Draft registration statement
12:00am
of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 662/3
424B4
dcsplitc dp
31 Aug 22
Prospectus supplement with pricing info
6:16am
S-1
EX-3.1
rh2yc4ucc1ba
3 Jun 22
IPO registration
5:32pm
S-1
EX-10.25
hzkd5h5
3 Jun 22
IPO registration
5:32pm
S-1
EX-10.27
4h3yysn7w32b9q9u1us
3 Jun 22
IPO registration
5:32pm
S-1
EX-3.3
0hrk aak6vy6w9t8cx
3 Jun 22
IPO registration
5:32pm
S-1
f3qo etv0ysw1r
3 Jun 22
IPO registration
5:32pm
DRS/A
ibwmf2 1k7
26 Apr 22
Draft registration statement (amended)
12:00am